Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. AGC Biologics S.p.A.
483
•AGC Biologics S.p.A.•November 20, 2023

AGC Biologics S.p.A. – FDA 483, Nov 20, 2023

Record Details

During an inspection conducted from November 8 to November 20, 2023, the FDA identified significant observations at AGC Biologics S.p.A., a cell and gene therapy manufacturer located in Bresso, Milan, Italy. The inspection revealed critical issues related to quality system failures and adherence to aseptic manufacturing procedures. A primary concern was the company's failure to identify the root cause and implement effective corrective actions for repeated non-viable particulate alarms in critical cleanroom areas, with 19 alarms during production and 40 without personnel, none adequately investigated. Furthermore, the company did not consistently follow its own procedures for addressing out-of-action particulate results, failing to verify or document required actions like material removal and sanitization. Additional observations highlighted procedural deviations by operators in aseptic processing areas, including rapid movements during sterile filtration and filling, contrary to established protocols, and replacing gloves without performing environmental monitoring. These observations, documented on an FDA Form 483, indicate deficiencies in maintaining a state of control and compliance with Good Manufacturing Practices. AGC Biologics S.p.A. is required to provide a comprehensive response detailing its corrective and preventive actions to address these findings and prevent recurrence.

Company
AGC Biologics S.p.A.
Inspection date
November 20, 2023
Product type
biologics
Office
Center for Biologics Evaluation and Research
People
  • Christina A. Casti.oeyla-CSO
  • Tiffany Lucas, CMC (FDA_PERSONNEL)
  • James B. Hare
  • Erin C. Hill
  • Lucas J. Bayne
View Company Profile

ID · 8022edf9-a581-413c-b061-3f367fa8e8b1

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore AGC Biologics S.p.A.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.